OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Autoimmunity is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	376
GILZ regulates type I interferon release and sequesters STAT1	225
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	187
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	131
Advances in SLE classification criteria	127
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	119
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	101
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	100
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	93
Editorial Board	93
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	89
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	86
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	80
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	76
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	74
Lupus nephritis: new progress in diagnosis and treatment	73
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	73
Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls	71
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	68
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	68
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	68
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	65
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	61
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	61
LAT1 enables T cell activation under inflammatory conditions	60

Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	59
The complement system and human autoimmune diseases	56
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	56
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	56
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	54
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	54
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	52
Editorial Board	50
Glycobiology of psoriasis: A review	50
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	48
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	48
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	47
Editorial Board	47
Editorial Board	46
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	45
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis	42
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	42
Antigenic mimicry – The key to autoimmunity in immune privileged organs	42
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review	41
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy	39
Editorial Board	39
Corrigendum to “Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19” [J. Autoimmun. 117C (2020) 102595]	38
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis	36
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study	36
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje	36
Familial patterns of alopecia areata: A systematic review and meta-analysis	36
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	35
Pregnancy-related complications in systemic lupus erythematosus	35
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis	35
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach	35
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis	32
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis	32
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study	31
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis	31
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice	30
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation	29
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	29
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	29
Interferon signature in giant cell arteritis aortitis	29
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study	28
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review	28
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis	28
Recent advances in cutaneous lupus	27
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease	27
Environmental exposures as risk factors for idiopathic inflammatory myopathies	27
T cell aging as a risk factor for autoimmunity	26
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	26
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?	26
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity	26
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study	25

Interleukin-15 is a hair follicle immune privilege guardian	24
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice	24
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study	24
Editorial Board	23
Extracellular vesicle autoantibodies	23
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases	23
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients	23
RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation	21
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening	21
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	21
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis	21
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome	21
T follicular helper cells in autoimmune diseases	20
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	20
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis	20
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	20
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	20
Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation	20
Editorial Board	20
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	19
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	19
Application of laboratory models for sarcoidosis research	19
Natural IgG protects against early dissemination of vesicular stomatitis virus	19
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	19
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	18
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	18
Telomeres: New players in immune-mediated inflammatory diseases?	18
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	18
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	18
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	18
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	18
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	17
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	17
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	17
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	17
Developmental drugs for sarcoidosis	17
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	17
Corrigendum to “Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies” [J. Autoimmun. 126 (2022) 102774]	17
Cognitive dysfunction in SLE: An understudied clinical manifestation	17
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	17
Treatment of mixed connective tissue disease: A multicenter retrospective study	16
Outcome and prognosis of isolated carotid vasculitis	16
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis	16
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis	16
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	16
Editorial Board	16
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement	16
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	16
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	16
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	16
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production	16
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis	15
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	15
PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis	15
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype	15
Pre-existing conditions associated with post-acute sequelae of COVID-19	15
Autoimmune hepatitis following COVID-19 vaccination	15
Autophagy pathways in autoimmune diseases	15
Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study	14
Editorial Board	14
Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments	14
Peripheral helper T cells in human diseases	14
Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus	13
SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases	13
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients	13
Diversity and function of regulatory T cells in health and autoimmune diseases	13
B cell-specific mAb–siRNA conjugates improve experimental myasthenia	13
Generation of self-reactive, shared T-cell receptor α chains in the human thymus	13
Editorial Board	13
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency	13
Loss of function of XBP1 splicing activity of IRE1α favors B cell tolerance breakdown	13
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review	13
Flagellin-specific human CAR Tregs for immune regulation in IBD	13
TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation	13
Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2	13